Zoekresultaten - 42 results

Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022

show a hospital-associated bloodstream infection (HABSI) cumulative incidence of 5.4 patients with HABSI per 1,000 hospitalisations, and a HABSI incidence density of 9.2 episodes per 10,000 patient-days ...

Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022

(NSIH- SEP) show a hospital-associated bloodstream infection (HABSI) cumulative incidence of 5.4 patients with HABSI per 1,000 hospitalisations, and a HABSI incidence density of 9.2 episodes per 10,000 ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...

Surveillance épidémiologique de la Varicelle et du Zona- varicella-zoster virus (VZV)- aperçu 2010-2022 et résultats détaillés 2019-2022

1 à 4 ans, suivis des moins d’1 an, furent les plus touchés que ce soit pour les consultations en médecine générale ou pour les hospitalisations. En moyenne 767 hospitalisations par an (diagnostics primaires ...

Social inequalities and long-term health impact of COVID-19 in Belgium: protocol of the HELICON population data linkage

a representative case-cohort study of 1.2 million randomly selected Belgians and 4.5 million Belgians with a confirmed COVID-19 diagnosis (PCR or antigen test), of which 108 211 are COVID-19 hospitalised patients ...

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.

on in-hospital deaths of laboratory-confirmed influenza patients in 11 European Union countries from 2010/11 to 2019/20.MethodsCase-based surveillance data from hospitalised patients with known age, ...

Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.

on the risk of COVID-19 hospitalisation. We analysed aggregated data from 27,608 COVID-19 patients hospitalised between October 2021 and February 2022, stratified by age category and vaccination ...

Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol

hospitalised patients with COVID-19, and national surveillance and screening data, and registries with over 1 900 000 COVID-19 cases across Europe, with continuous updates. These heterogeneous datasets will be ...

QR code

QR code for this page URL